sulfadimethoxine has been researched along with Follicular Thyroid Carcinoma in 4 studies
Sulfadimethoxine: A sulfanilamide that is used as an anti-infective agent.
sulfadimethoxine : A sulfonamide consisting of pyrimidine having methoxy substituents at the 2- and 6-positions and a 4-aminobenzenesulfonamido group at the 4-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We previously demonstrated that thyroid capsular inflammation induced by continuous treatment with the antithyroidal agent sulfadimethoxine is associated with development of invasive follicular cell carcinomas in rats initiated with N-bis(2-hydroxypropyl)nitrosamine (DHPN)." | 7.74 | Depression of T cell-mediated immunity reduces sulfadimethoxine-induced capsular inflammation and inhibits associated development of invasive thyroid follicular cell carcinomas in rats. ( Cho, YM; Hasumura, M; Hirose, M; Imai, T; Onose, J, 2007) |
| "We have reported that thyroid capsular thickening with inflammation induced by an antithyroidal agent, sulfadimethoxine (SDM), might play a role in the development of invasive follicular carcinomas in rats initiated with N-bis(2-hydroxypropyl)nitrosamine (DHPN)." | 3.75 | Inhibitory effects of aminoguanidine on thyroid follicular carcinoma development in inflamed capsular regions of rats treated with sulfadimethoxine after N-bis(2-hydroxypropyl)nitrosamine-initiation. ( Cho, YM; Hasumura, M; Hirose, M; Imai, T; Nishikawa, A; Ota, Y; Takami, S, 2009) |
| "We previously demonstrated that thyroid capsular inflammation induced by continuous treatment with the antithyroidal agent sulfadimethoxine is associated with development of invasive follicular cell carcinomas in rats initiated with N-bis(2-hydroxypropyl)nitrosamine (DHPN)." | 3.74 | Depression of T cell-mediated immunity reduces sulfadimethoxine-induced capsular inflammation and inhibits associated development of invasive thyroid follicular cell carcinomas in rats. ( Cho, YM; Hasumura, M; Hirose, M; Imai, T; Onose, J, 2007) |
| "We have previously reported that thyroid capsular inflammation induced by sulfadimethoxine (SDM), a goitrogen, might play a role in development of invasive follicular cell adenocarcinomas in rats initiated with N-bis(2-hydroxypropyl)nitrosamine (DHPN)." | 3.73 | Development of invasive follicular cell carcinomas in a rat thyroid carcinogenesis model: biological impact of capsular inflammation and reduced cyclooxygenase-2 expression. ( Cho, YM; Hasumura, M; Hirose, M; Imai, T; Onose, J; Takizawa, T; Ueda, M, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imai, T | 4 |
| Hasumura, M | 4 |
| Cho, YM | 4 |
| Ota, Y | 2 |
| Takami, S | 2 |
| Hirose, M | 4 |
| Nishikawa, A | 2 |
| Oyamada, T | 1 |
| Ogawa, K | 1 |
| Onose, J | 2 |
| Ueda, M | 1 |
| Takizawa, T | 1 |
4 other studies available for sulfadimethoxine and Follicular Thyroid Carcinoma